CN103804267B - 一种维达列汀的合成工艺 - Google Patents
一种维达列汀的合成工艺 Download PDFInfo
- Publication number
- CN103804267B CN103804267B CN201410059387.8A CN201410059387A CN103804267B CN 103804267 B CN103804267 B CN 103804267B CN 201410059387 A CN201410059387 A CN 201410059387A CN 103804267 B CN103804267 B CN 103804267B
- Authority
- CN
- China
- Prior art keywords
- vildagliptin
- reaction
- pyrrolidine
- cyanogen
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410059387.8A CN103804267B (zh) | 2014-02-21 | 2014-02-21 | 一种维达列汀的合成工艺 |
PCT/CN2014/089248 WO2015123998A1 (zh) | 2014-02-21 | 2014-10-23 | 一种维达列汀的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410059387.8A CN103804267B (zh) | 2014-02-21 | 2014-02-21 | 一种维达列汀的合成工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103804267A CN103804267A (zh) | 2014-05-21 |
CN103804267B true CN103804267B (zh) | 2016-06-08 |
Family
ID=50701707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410059387.8A Active CN103804267B (zh) | 2014-02-21 | 2014-02-21 | 一种维达列汀的合成工艺 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103804267B (zh) |
WO (1) | WO2015123998A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103804267B (zh) * | 2014-02-21 | 2016-06-08 | 张家港威胜生物医药有限公司 | 一种维达列汀的合成工艺 |
WO2015145467A1 (en) * | 2014-03-28 | 2015-10-01 | Laurus Labs Private Limited | An improved process for preparing vildagliptin |
CN114031629A (zh) * | 2021-12-10 | 2022-02-11 | 山东安舜制药有限公司 | 一种合成他唑巴坦中间体的方法 |
CN114230503A (zh) * | 2021-12-10 | 2022-03-25 | 山东安舜制药有限公司 | 一锅法合成维格列汀的方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080167479A1 (en) * | 2007-01-10 | 2008-07-10 | Medichem, S.A. | Process for preparing vildagliptin |
CN101318922A (zh) * | 2007-06-08 | 2008-12-10 | 上海阳帆医药科技有限公司 | 一类新型二肽基肽酶抑制剂、合成方法和用途 |
WO2010022690A2 (en) * | 2008-08-26 | 2010-03-04 | Zentiva, K.S. | A method of preparation of highly pure vildagliptin |
CN101918423A (zh) * | 2007-11-30 | 2010-12-15 | 诺瓦提斯公司 | 有机化合物 |
WO2011012322A2 (en) * | 2009-07-31 | 2011-02-03 | Krka, D.D., Novo Mesto | Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms |
CN102617434A (zh) * | 2012-03-29 | 2012-08-01 | 中国科学院上海有机化学研究所 | 一锅法制备维达列汀 |
WO2013179300A2 (en) * | 2012-05-04 | 2013-12-05 | Megafine Pharma (P) Ltd. | A process for the preparation of vildagliptin and its intermediate thereof |
CN103435526A (zh) * | 2013-08-22 | 2013-12-11 | 天津速研医药科技有限公司 | 一种维达列汀的合成方法 |
WO2014020462A1 (en) * | 2012-08-01 | 2014-02-06 | Alembic Pharmaceuticals Limited | Improved process for preparation of vildagliptin intermediate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011101861A1 (en) * | 2010-01-29 | 2011-08-25 | Msn Laboratories Limited | Process for preparation of dpp-iv inhibitors |
CN103804267B (zh) * | 2014-02-21 | 2016-06-08 | 张家港威胜生物医药有限公司 | 一种维达列汀的合成工艺 |
-
2014
- 2014-02-21 CN CN201410059387.8A patent/CN103804267B/zh active Active
- 2014-10-23 WO PCT/CN2014/089248 patent/WO2015123998A1/zh active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080167479A1 (en) * | 2007-01-10 | 2008-07-10 | Medichem, S.A. | Process for preparing vildagliptin |
CN101318922A (zh) * | 2007-06-08 | 2008-12-10 | 上海阳帆医药科技有限公司 | 一类新型二肽基肽酶抑制剂、合成方法和用途 |
CN101918423A (zh) * | 2007-11-30 | 2010-12-15 | 诺瓦提斯公司 | 有机化合物 |
WO2010022690A2 (en) * | 2008-08-26 | 2010-03-04 | Zentiva, K.S. | A method of preparation of highly pure vildagliptin |
WO2011012322A2 (en) * | 2009-07-31 | 2011-02-03 | Krka, D.D., Novo Mesto | Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms |
CN102617434A (zh) * | 2012-03-29 | 2012-08-01 | 中国科学院上海有机化学研究所 | 一锅法制备维达列汀 |
WO2013179300A2 (en) * | 2012-05-04 | 2013-12-05 | Megafine Pharma (P) Ltd. | A process for the preparation of vildagliptin and its intermediate thereof |
WO2014020462A1 (en) * | 2012-08-01 | 2014-02-06 | Alembic Pharmaceuticals Limited | Improved process for preparation of vildagliptin intermediate |
CN103435526A (zh) * | 2013-08-22 | 2013-12-11 | 天津速研医药科技有限公司 | 一种维达列汀的合成方法 |
Non-Patent Citations (2)
Title |
---|
(S)-1-(2-氯乙酰基)吡咯烷-2-甲腈的合成与表征;王延安,等;《精细化工中间体》;20100228;第40卷(第01期);第27-30页 * |
Synthesis and structure–activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors;Hiroshi Fukushima,等;《Bioorganic & Medicinal Chemistry》;20080116;第16卷(第7期);第4093-4106页 * |
Also Published As
Publication number | Publication date |
---|---|
WO2015123998A1 (zh) | 2015-08-27 |
CN103804267A (zh) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104447443B (zh) | 一种阿普斯特及其中间体的制备方法 | |
CN103804267B (zh) | 一种维达列汀的合成工艺 | |
CN103073438B (zh) | 一种盐酸氨溴索化合物的精制方法 | |
CN106966947B (zh) | 一种维格列汀的制备方法 | |
EP3828170A1 (en) | Method for safely preparing pimavanserin and tartrate salt thereof using triphosgene | |
CN110511152B (zh) | 一种伏格列波糖杂质i盐酸盐的制备方法 | |
CN104945299A (zh) | 一种维格列汀的高效合成方法 | |
CN105294673A (zh) | 一种氢溴酸替格列汀的合成方法 | |
CN108059601A (zh) | 一种制备3-氨基-1-金刚烷醇的工艺 | |
CN104628622A (zh) | 一种沙格列汀中间体的制备方法 | |
CN104326990B (zh) | 一种胞嘧啶氟化合成5-氟胞嘧啶的方法 | |
CN106631903A (zh) | 一种lcz‑696关键中间体的制备方法 | |
CN104649920B (zh) | 一种门冬氨酸鸟氨酸的制备方法 | |
CN103641761A (zh) | 一种维格利汀的制备方法 | |
CN105646446A (zh) | 一种纯化阿格列汀的方法 | |
CN100532373C (zh) | (2r,3s)-环氧-9-辛烯-1-醇的全合成方法 | |
CN110092738B (zh) | 维格列汀的制备方法 | |
CN109942514A (zh) | 一种制备硫酸阿扎拉韦中间体的方法 | |
CN102070513B (zh) | 1-叔丁氧羰基-4-哌啶酮的合成方法 | |
CN108395387A (zh) | 一种溴米索伐的合成方法 | |
CN108129525B (zh) | 一种依托泊苷中间体的制备方法 | |
CN102603595A (zh) | (s)-奥拉西坦的制备方法 | |
CN102603594A (zh) | (s)-奥拉西坦的制备方法 | |
CN101012181B (zh) | Dl-对氯苯丙氨酸的拆分方法 | |
CN110713471B (zh) | 一种盐酸曲美他嗪的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic process of vidaletin Effective date of registration: 20210930 Granted publication date: 20160608 Pledgee: Agricultural Bank of China Limited Zhangjiagang branch Pledgor: ZHANG JIA GANG VINSCE BIO-PHARM Co.,Ltd. Registration number: Y2021320010400 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 2, Nanjing Middle Road, Jiangsu Yangzijiang Chemical Industrial Park, Zhangjiagang Free Trade Zone, Suzhou City, Jiangsu Province, 215634 Patentee after: Wison Biomedical (Suzhou) Co.,Ltd. Address before: 215634 No. 2 Nanjing Middle Road, Yangtze River Chemical Industrial Park, Zhangjiagang Free Trade Zone, Suzhou City, Jiangsu Province Patentee before: Weisheng Biomedical (Suzhou) Co.,Ltd. Address after: 215634 No. 2 Nanjing Middle Road, Yangtze River Chemical Industrial Park, Zhangjiagang Free Trade Zone, Suzhou City, Jiangsu Province Patentee after: Weisheng Biomedical (Suzhou) Co.,Ltd. Address before: 215634 Building D, No. 7 Guangdong Road, Zhangjiagang Free Trade Zone, Suzhou City, Jiangsu Province (Weisheng) Patentee before: ZHANG JIA GANG VINSCE BIO-PHARM Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221031 Granted publication date: 20160608 Pledgee: Agricultural Bank of China Limited Zhangjiagang branch Pledgor: ZHANG JIA GANG VINSCE BIO-PHARM Co.,Ltd. Registration number: Y2021320010400 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |